• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三叉神经痛全内镜下微血管减压术后复发的危险因素:一项回顾性研究及预测列线图

Risk factors for postoperative recurrence after full-endoscopic microvascular decompression for trigeminal neuralgia: a retrospective study and predictive nomogram.

作者信息

Peng Weicheng, Xiang Xinli, Li Zhehong, Zhao Rui, Liang Xin, Guan Feng, Hu Zhiqiang

机构信息

Department of Neurosurgery, Neuromedicine Center, Beijing Shijitan Hospital, Capital Medical University, No. 10, Tieyi Road, Yangfangdian, Haidian District, Beijing, 100038, People's Republic of China.

Department of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, No. 10, Tieyi Road, Yangfangdian, Haidian District, Beijing, 100038, People's Republic of China.

出版信息

Eur J Med Res. 2024 Dec 23;29(1):613. doi: 10.1186/s40001-024-02205-8.

DOI:10.1186/s40001-024-02205-8
PMID:39710776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11665137/
Abstract

BACKGROUND

Full-endoscopic microvascular decompression (fE-MVD) is an emerging treatment option for trigeminal neuralgia (TN). However, the risk factors associated with postoperative recurrence of TN after fE-MVD procedure remain controversial. The aim of the present study was to summarize the surgical technique of fE-MVD for the treatment of TN and to develop a predictive model for recurrence at 1 year postoperatively based on independent risk factors.

METHODS

A total of 124 consecutive patients with TN who underwent fE-MVD procedure were enrolled in this study between December 2008 and July 2022. Imaging data such as the area of cerebellopontine angle (CPA), the length of trigeminal cisternal segment, and the angle of trigeminal nerve (TGN) were measured from preoperative magnetic resonance imaging (MRI). Patients were randomly divided into a training set and a validation set according to the 7:3 ratio, respectively. Variables that were significant in the univariate logistic analyses were, subsequently, included in the multivariate logistic regression analyses in training set. Then, we developed a predictive nomogram for the 1-year recurrence of TN for patients who treated with fE-MVD.

RESULTS

All 124 patients experienced clinically significant pain relief (Barrow Neurology Institute (BNI) I-II) after fE-MVD. 124 patients had a follow-up time of more than 1 year, with 14 cases of recurrence. In the univariate analysis, the patients' responsible vessels of non-arterial, clinical features of atypical, and CPA area ratio (healthy/affected side) >1 were found to be significantly associated with recurrence of TN after fE-MVD. Multivariate logistic regression analyses result showed that the patients' responsible vessels of non-arterial (odds ratio (OR) = 21.067, 95% confidence interval (CI): 1.942-228.575), clinical features of atypical (OR = 9.027, 95% CI: 1.135-71.777), and CPA area ratio >1 (OR = 19.522, 95% CI: 2.906-131.160) were independent predictors of TN recurrence. Based on the independent predictive factors, we developed a predictive nomogram that predicts the 1-year recurrence of TN after fE-MVD. In the receiver operating characteristic (ROC) curve analysis, the area under the curve (AUC) of the nomograms for 1-year recurrence associated with optimal candidates prediction was 0.910 in the training set and 0.859 in the validation set.

CONCLUSIONS

FE-MVD for the treatment of TN is a safe, reliable and effective procedure. Patients' responsible vessels of non-arterial, clinical features of atypical, and CPA area ratio (healthy/affected side) >1 are key risk factors associated with 1 year postoperative recurrence of TN after fE-MVD. Finally, we have developed a nomogram to predict the 1-year recurrence of TN for patients who treated with fE-MVD, which can be used to provide advice for patients after fE-MVD.

摘要

背景

全内镜下微血管减压术(fE-MVD)是治疗三叉神经痛(TN)的一种新兴治疗选择。然而,fE-MVD术后TN复发的相关危险因素仍存在争议。本研究的目的是总结fE-MVD治疗TN的手术技术,并基于独立危险因素建立术后1年复发的预测模型。

方法

2008年12月至2022年7月期间,共有124例连续接受fE-MVD手术的TN患者纳入本研究。术前磁共振成像(MRI)测量桥小脑角(CPA)面积、三叉神经脑池段长度和三叉神经(TGN)角度等影像数据。患者按7:3的比例随机分为训练集和验证集。单因素逻辑分析中有统计学意义的变量随后纳入训练集的多因素逻辑回归分析。然后,我们为接受fE-MVD治疗的患者建立了TN 1年复发的预测列线图。

结果

所有124例患者在fE-MVD术后均有临床显著的疼痛缓解(巴罗神经学研究所(BNI)I-II级)。124例患者随访时间超过1年,其中14例复发。单因素分析发现,非动脉性责任血管、非典型临床特征以及CPA面积比(健侧/患侧)>1与fE-MVD术后TN复发显著相关。多因素逻辑回归分析结果显示,非动脉性责任血管(比值比(OR)=21.067,95%置信区间(CI):1.942-228.575)、非典型临床特征(OR = 9.027,95% CI:1.135-71.777)和CPA面积比>1(OR = 19.522,95% CI:2.906-131.160)是TN复发的独立预测因素。基于这些独立预测因素,我们建立了一个预测列线图,用于预测fE-MVD术后TN的1年复发情况。在受试者工作特征(ROC)曲线分析中,训练集中与最佳候选预测相关的1年复发列线图曲线下面积(AUC)为0.910,验证集中为0.859。

结论

fE-MVD治疗TN是一种安全、可靠且有效的手术。非动脉性责任血管、非典型临床特征以及CPA面积比(健侧/患侧)>1是fE-MVD术后TN 1年复发的关键危险因素。最后,我们建立了一个列线图来预测接受fE-MVD治疗患者的TN 1年复发情况,可为fE-MVD术后患者提供建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb8/11665137/b5c6d9354509/40001_2024_2205_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb8/11665137/4cb18f6ae242/40001_2024_2205_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb8/11665137/27c0bbb3806d/40001_2024_2205_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb8/11665137/b5c6d9354509/40001_2024_2205_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb8/11665137/4cb18f6ae242/40001_2024_2205_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb8/11665137/27c0bbb3806d/40001_2024_2205_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb8/11665137/b5c6d9354509/40001_2024_2205_Fig3_HTML.jpg

相似文献

1
Risk factors for postoperative recurrence after full-endoscopic microvascular decompression for trigeminal neuralgia: a retrospective study and predictive nomogram.三叉神经痛全内镜下微血管减压术后复发的危险因素:一项回顾性研究及预测列线图
Eur J Med Res. 2024 Dec 23;29(1):613. doi: 10.1186/s40001-024-02205-8.
2
Fully endoscopic microvascular decompression for the treatment of hemifacial spasm, trigeminal neuralgia, and glossopharyngeal neuralgia: a retrospective study.内镜下微血管减压术治疗面肌痉挛、三叉神经痛和舌咽神经痛:回顾性研究。
BMC Surg. 2023 Oct 27;23(1):331. doi: 10.1186/s12893-023-02214-0.
3
Endoscopic versus microscopic microvascular decompression for trigeminal neuralgia: equivalent pain outcomes with possibly decreased postoperative headache after endoscopic surgery.内镜与显微镜下微血管减压术治疗三叉神经痛:内镜手术后可能头痛发生率更低,疼痛缓解效果相当。
J Neurosurg. 2017 May;126(5):1676-1684. doi: 10.3171/2016.5.JNS1621. Epub 2016 Jul 29.
4
Prospective comparison of long-term pain relief rates after first-time microvascular decompression and stereotactic radiosurgery for trigeminal neuralgia.首次微血管减压术与立体定向放射外科治疗三叉神经痛后长期疼痛缓解率的前瞻性比较。
J Neurosurg. 2018 Jan;128(1):68-77. doi: 10.3171/2016.9.JNS16149. Epub 2017 Feb 24.
5
Prognostic nomogram for microvascular decompression-treated trigeminal neuralgia.微血管减压治疗三叉神经痛的预后列线图。
Neurosurg Rev. 2021 Feb;44(1):571-577. doi: 10.1007/s10143-020-01251-0. Epub 2020 Feb 10.
6
Outcomes and safety of repeated microvascular decompression for recurrent trigeminal neuralgia.复发性三叉神经痛重复微血管减压术的疗效与安全性
Neurosurg Rev. 2025 May 8;48(1):407. doi: 10.1007/s10143-025-03559-1.
7
Microvascular Decompression for Trigeminal Neuralgia in Patients with Multiple Sclerosis: Predictors of Treatment Success.多发性硬化症患者三叉神经痛的微血管减压术:治疗成功的预测因素
World Neurosurg. 2020 Apr;136:e165-e170. doi: 10.1016/j.wneu.2019.12.081. Epub 2019 Dec 23.
8
Predicting long-term outcomes in patients with classical trigeminal neuralgia following microvascular decompression with an MRI-based radiomics nomogram: a multicentre study.基于 MRI 放射组学列线图预测微血管减压术后经典三叉神经痛患者的长期预后:一项多中心研究。
Eur Radiol. 2024 Nov;34(11):7349-7361. doi: 10.1007/s00330-024-10775-8. Epub 2024 May 8.
9
Fully endoscopic microvascular decompression for trigeminal neuralgia: technical note and early outcomes.全内镜下微血管减压术治疗三叉神经痛:技术要点及早期疗效。
Neurosurg Rev. 2023 Nov 1;46(1):292. doi: 10.1007/s10143-023-02188-w.
10
Fully Endoscopic Microvascular Decompression for Trigeminal Neuralgia: Technical Note Describing a Single-Center Experience.全内镜下微血管减压术治疗三叉神经痛:单中心经验技术描述。
World Neurosurg. 2022 Oct;166:159-167. doi: 10.1016/j.wneu.2022.07.014. Epub 2022 Jul 8.

引用本文的文献

1
Microvascular Decompression for Trigeminal Neuralgia Using Autologous Muscle Grafting: A Retrospective Analysis in a Resource-Limited Setting.自体肌肉移植微血管减压术治疗三叉神经痛:资源有限环境下的回顾性分析
Cureus. 2025 Mar 28;17(3):e81362. doi: 10.7759/cureus.81362. eCollection 2025 Mar.

本文引用的文献

1
Fully endoscopic microvascular decompression for the treatment of hemifacial spasm, trigeminal neuralgia, and glossopharyngeal neuralgia: a retrospective study.内镜下微血管减压术治疗面肌痉挛、三叉神经痛和舌咽神经痛:回顾性研究。
BMC Surg. 2023 Oct 27;23(1):331. doi: 10.1186/s12893-023-02214-0.
2
Microvascular decompression in trigeminal neuralgia - a prospective study of 115 patients.微血管减压术治疗三叉神经痛——115 例前瞻性研究。
J Headache Pain. 2022 Nov 19;23(1):145. doi: 10.1186/s10194-022-01520-x.
3
Analysis of the Hemodynamic Response During Radiofrequency Thermocoagulation in Trigeminal Neuralgia.
分析射频热凝治疗三叉神经痛过程中的血液动力学反应。
Pain Physician. 2022 Oct;25(7):E1057-E1062.
4
Results of three or more Gamma Knife radiosurgery procedures for recurrent trigeminal neuralgia.三次或以上伽玛刀放射外科手术治疗复发性三叉神经痛的结果。
J Neurosurg. 2021 Apr 23;135(6):1789-1798. doi: 10.3171/2020.10.JNS202323. Print 2021 Dec 1.
5
Recurrence Rates After Microvascular Decompression in Patients With Primary Trigeminal Neuralgia and Its Influencing Factors: A Systematic Review and Meta-Analysis Based on 8,172 Surgery Patients.原发性三叉神经痛患者微血管减压术后的复发率及其影响因素:基于8172例手术患者的系统评价和Meta分析
Front Neurol. 2021 Sep 30;12:738032. doi: 10.3389/fneur.2021.738032. eCollection 2021.
6
Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia.三叉神经痛的诊断、分类、病理生理学和治疗进展。
Lancet Neurol. 2020 Sep;19(9):784-796. doi: 10.1016/S1474-4422(20)30233-7.
7
Trigeminal Neuralgia.三叉神经痛
N Engl J Med. 2020 Aug 20;383(8):754-762. doi: 10.1056/NEJMra1914484.
8
Prognostic nomogram for microvascular decompression-treated trigeminal neuralgia.微血管减压治疗三叉神经痛的预后列线图。
Neurosurg Rev. 2021 Feb;44(1):571-577. doi: 10.1007/s10143-020-01251-0. Epub 2020 Feb 10.
9
European Academy of Neurology guideline on trigeminal neuralgia.欧洲神经病学学会三叉神经痛指南。
Eur J Neurol. 2019 Jun;26(6):831-849. doi: 10.1111/ene.13950. Epub 2019 Apr 8.
10
A Meta-Analysis of Endoscopic Microvascular Decompression versus Microscopic Microvascular Decompression for the Treatment for Cranial Nerve Syndrome Caused by Vascular Compression.内镜下微血管减压术与显微镜下微血管减压术治疗血管压迫性颅神经综合征的荟萃分析。
World Neurosurg. 2019 Jun;126:647-655.e7. doi: 10.1016/j.wneu.2019.01.220. Epub 2019 Feb 15.